CD38 in Neurodegeneration and Neuroinflammation
- PMID: 32085567
- PMCID: PMC7072759
- DOI: 10.3390/cells9020471
CD38 in Neurodegeneration and Neuroinflammation
Abstract
Neurodegenerative diseases are characterized by neuronal degeneration as well as neuroinflammation. While CD38 is strongly expressed in brain cells including neurons, astrocytes as well as microglial cells, the role played by CD38 in neurodegeneration and neuroinflammation remains elusive. Yet, CD38 expression increases as a consequence of aging which is otherwise the primary risk associated with neurodegenerative diseases, and several experimental data demonstrated that CD38 knockout mice are protected from neurodegenerative and neuroinflammatory insults. Moreover, nicotinamide adenine dinucleotide, whose levels are tightly controlled by CD38, is a recognized and potent neuroprotective agent, and NAD supplementation was found to be beneficial against neurodegenerative diseases. The aims of this review are to summarize the physiological role played by CD38 in the brain, present the arguments indicating the involvement of CD38 in neurodegeneration and neuroinflammation, and to discuss these observations in light of CD38 complex biology.
Keywords: ALS.; Alzheimer’s disease; CD38; NAD; Parkinson’s disease; aging; neurodegeneration; neuroinflammation.
Conflict of interest statement
S.G, L.B., D.T. are founders and shareholders of Encefa. A.-L.P. is employed by Encefa. Encefa is a biotechnology company developing an anti-CD38 antibody against neurodegenerative diseases.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
